Literature DB >> 17009842

New silver polypyridyl complexes: synthesis, characterization and biological activity on Leishmania mexicana.

Maribel Navarro1, Efrén J Cisneros-Fajardo, Edgar Marchan.   

Abstract

Leishmania parasites are the causal agents of leishmaniasis that currently threatens 350 million people in 88 different countries, in the absence of an effective drug. In order to continue the development of transition metal complexes with planar ligands that show interactions with DNA and activity against Leishmania parasites, the synthesis of the complexes [Ag(dpq)2]NO3 (1) and [Ag(dppz)2]NO3 (2), which were obtained by the reaction of silver nitrate with dpq and dppz, respectively, in a 1:2 molar ratio is reported. These complexes were characterized by elemental analysis and 1H-NMR, IR, and UV-vis spectroscopies. The most probable structure for these complexes is tetrahedral, with two molecules of ligand coordinated to the silver atom and a nitrate as a counter ion. Affinity studies of DNA vs. bovine albumin were carried out, and a strong interaction of the complexes with DNA was observed. Bioassays were undertaken in vitro on promastigotes of Leishmania (L.) mexicana exposed to the silver complexes for 48 h. At 10 micromol/L complex 2 induced a leishmanicidal effect (LD23), whilst complex 1 reduced the parasites growth rate by 55% (LD55). These findings suggest that biological activity could be associated with the interaction of the complexes with the parasitic DNA.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17009842     DOI: 10.1055/s-0031-1296758

Source DB:  PubMed          Journal:  Arzneimittelforschung        ISSN: 0004-4172


  8 in total

1.  Metal-drug synergy: new ruthenium(II) complexes of ketoconazole are highly active against Leishmania major and Trypanosoma cruzi and nontoxic to human or murine normal cells.

Authors:  Eva Iniguez; Antonio Sánchez; Miguel A Vasquez; Alberto Martínez; Joanna Olivas; Aaron Sattler; Roberto A Sánchez-Delgado; Rosa A Maldonado
Journal:  J Biol Inorg Chem       Date:  2013-07-24       Impact factor: 3.358

2.  Searching for new chemotherapies for tropical diseases: ruthenium-clotrimazole complexes display high in vitro activity against Leishmania major and Trypanosoma cruzi and low toxicity toward normal mammalian cells.

Authors:  Alberto Martínez; Teresia Carreon; Eva Iniguez; Atilio Anzellotti; Antonio Sánchez; Marina Tyan; Aaron Sattler; Linda Herrera; Rosa A Maldonado; Roberto A Sánchez-Delgado
Journal:  J Med Chem       Date:  2012-04-09       Impact factor: 7.446

3.  Synthesis and evaluation of the antileishmanial activity of silver compounds containing imidazolidine-2-thione.

Authors:  Patrícia Ferreira Espuri; Larissa Luiza Dos Reis; Eduardo de Figueiredo Peloso; Vanessa Silva Gontijo; Fábio Antônio Colombo; Juliana Barbosa Nunes; Carine Ervolino de Oliveira; Eduardo T De Almeida; Débora E S Silva; Jessica Bortoletto; Daniel Fonseca Segura; Adelino V G Netto; Marcos José Marques
Journal:  J Biol Inorg Chem       Date:  2019-04-04       Impact factor: 3.358

4.  Inhibitory Effect of Silver Nanoparticles on Trypanothione Reductase Activity and Leishmania infantum Proliferation.

Authors:  Paola Baiocco; Andrea Ilari; Pierpaolo Ceci; Stefania Orsini; Marina Gramiccia; Trentina Di Muccio; Gianni Colotti
Journal:  ACS Med Chem Lett       Date:  2010-12-29       Impact factor: 4.345

5.  Activity of Auranofin against Multiple Genotypes of Naegleria fowleri and Its Synergistic Effect with Amphotericin B In Vitro.

Authors:  Jose Ignacio Escrig; Hye Jee Hahn; Anjan Debnath
Journal:  ACS Chem Neurosci       Date:  2020-05-26       Impact factor: 4.418

6.  Dressings combined with injection of meglumine antimoniate in the treatment of cutaneous leishmaniasis: a randomized controlled clinical trial.

Authors:  Alireza Khatami; Rezvan Talaee; Makan Rahshenas; Ali Khamesipour; Pedram Mehryan; Sepideh Tehrani; Yahya Dowlati; Alireza Firooz
Journal:  PLoS One       Date:  2013-06-24       Impact factor: 3.240

7.  Rapid healing of cutaneous leishmaniasis by high-frequency electrocauterization and hydrogel wound care with or without DAC N-055: a randomized controlled phase IIa trial in Kabul.

Authors:  Ahmad Fawad Jebran; Ulrike Schleicher; Reto Steiner; Pia Wentker; Farouq Mahfuz; Hans-Christian Stahl; Faquir Mohammad Amin; Christian Bogdan; Kurt-Wilhelm Stahl
Journal:  PLoS Negl Trop Dis       Date:  2014-02-13

8.  Antileishmanial metallodrugs and the elucidation of new drug targets linked to post-translational modifications machinery: pitfalls and progress.

Authors:  Rubens Lima do Monte Neto; Paulo Otávio Lourenço Moreira; Alessandra Mara de Sousa; Miguel Antonio do Nascimento Garcia; Suellen Rodrigues Maran; Nilmar Silvio Moretti
Journal:  Mem Inst Oswaldo Cruz       Date:  2022-03-23       Impact factor: 2.743

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.